Celebrex In Acute Gouty Arthritis Study

NCT00549549 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Gouty

Interventions

DRUG: Indomethacin
DRUG: Celecoxib
DRUG: Celecoxib
DRUG: Celecoxib

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.